ARC Document Solutions, Inc.

    ARC Document Solutions, Inc.

    NNYSE:ARC
    3.39
    USD
    0.00
    (0.00%)
    30.27P/E
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    9.31
    8.89
    8.88
    9.16
    9.19
    8.85
    8.64
    8.92
    8.5
    6.74
    6.46
    6.78
    6.61
    6.83
    Basic EPS, GAAP
    -2.93
    -0.7
    -0.33
    0.16
    2.08
    -1.04
    -0.47
    0.2
    0.07
    0.14
    0.22
    0.26
    0.19
    0.11
    Free Cash Flow per Basic Share
    1.08
    0.82
    1.02
    1.08
    1.29
    1.16
    1.15
    1.22
    1.17
    1.27
    0.85
    0.88
    0.86
    0.78
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.02
    0.07
    0.2
    0.2
    0.2
    Book Value per Share
    0.72
    0.02
    -0.32
    -0.16
    1.92
    0.91
    0.45
    0.66
    0.71
    0.87
    0.99
    1.05
    1.04
    1.02
    Tangible Book Value per Share
    -3.03
    -2.98
    -3.08
    -2.74
    -0.46
    0.11
    0.16
    0.47
    0.6
    0.76
    0.89
    0.83
    0.81
    0.83
    Basic Weighted Avg Shares
    45
    46
    46
    46
    47
    46
    46
    45
    45
    43
    42
    42
    43
    42
    Sales/Revenue/Turnover
    423
    406
    407
    424
    429
    406
    395
    401
    382
    289
    272
    286
    281
    289
    Operating Margin (%)
    3.38
    4.78
    7.59
    7.23
    8.21
    6.94
    4.52
    4.46
    3.86
    4.28
    5.56
    6.42
    6.41
    4.78
    Depreciation Expense
    48
    40
    35
    34
    34
    32
    33
    33
    32
    30
    25
    20
    18
    16
    Net Income, GAAP
    -133
    -32
    -15
    7
    97
    -48
    -22
    9
    3
    6
    9
    11
    8
    5
    Effective Tax Rate (%)
    - -
    - -
    - -
    24.01
    - -
    - -
    - -
    27.64
    66.84
    32.18
    32.1
    35.09
    35.21
    47.45
    Profit Margin (%)
    -31.48
    -7.87
    -3.76
    1.72
    22.64
    -11.78
    -5.45
    2.21
    0.79
    2.14
    3.36
    3.88
    2.93
    1.61
    Working Capital
    40
    41
    29
    21
    40
    45
    40
    34
    20
    33
    37
    35
    37
    37
    LT Debt
    211
    209
    198
    176
    157
    143
    124
    105
    126
    113
    89
    78
    81
    80
    Total Equity
    137
    111
    99
    110
    209
    157
    138
    147
    150
    154
    159
    156
    156
    157
    Return on Invested Capital (%)
    - -
    - -
    - -
    7.41
    - -
    - -
    - -
    4.68
    1.7
    2.81
    3.63
    4.54
    4.6
    2.89
    Return on Capital (%)
    - -
    - -
    - -
    8.74
    - -
    - -
    - -
    7.9
    2.76
    4.86
    6.25
    8.16
    6.49
    3.83
    Return on Common Equity (%)
    -129.08
    -191.14
    - -
    - -
    - -
    -72.74
    -68.9
    35.48
    9.81
    17.84
    23.1
    25.71
    18.58
    10.29

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    18
    18
    18
    LT Borrowings
    53
    52
    52
    LT Finance Leases
    29
    28
    27
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    43
    43
    43
    Market Capitalization
    112
    108
    141

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    107
    110
    112
    Cash, Cash Equivalents & STI
    52
    50
    51
    Accounts Receivable, Net
    38
    42
    42
    Inventories
    9
    9
    9
    Total Current Liabilities
    69
    71
    75
    Payables & Accruals
    51
    54
    57
    ST Debt
    18
    18
    18
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    7.66%
    1.14%
    -0.36%
    Free Cash Flow
    -1.38%
    -6.55%
    -1.73%
    Net Income, GAAP
    82.33%
    16.51%
    -25.77%
    Sales/Revenue/Turnover
    -3.28%
    -6.29%
    -1.68%
    Total Cash Common Dividend
    - -
    - -
    0.83%

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    69
    75
    73
    69
    286
    2023
    69
    72
    71
    69
    281
    2024
    71
    75
    74
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.05
    0.08
    0.09
    0.05
    0.26
    2023
    0.05
    0.09
    0.07
    - -
    0.19
    2024
    0.06
    0.07
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.05
    0.05
    0.05
    0.05
    0.2
    2023
    0.05
    0.05
    0.05
    - -
    0.2
    2024
    0.05
    0.05
    0.05
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer

    • Octave Named a Leader in Both EAM and Digital Worker Technologies MarketMap by ARC Advisory Group

    • ARC Group Securities Acquisition I Announces the Separate Trading of its Class A Ordinary Shares, Warrants and Rights Commencing September 24, 2026

    • Firstborn Top Capital, a Licensed Private Financing Company in Malaysia, to Become Publicly Traded Via Business Combination with ARC Group Acquisition I Corp

    • Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

    • ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline

    • Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

    • ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury

    • ARC Group Securities Acquisition I Announces Pricing of $105,000,000 Initial Public Offering

    • ARC Resources Ltd. (ARX:CA) Shareholder/Analyst Call Prepared Remarks Transcript

    • ARC shareholders approve $16.4 billion Shell deal

    • TRWD Reserves “ARC Entertainment Group” Name to Anchor Its Multi-Brand Platform

    • ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER

    • Can GlobalFoundries' ARC Acquisition Strengthen Its Physical AI Push?

    • Exclusive distribution agreement marks Nanox's entry into the Peruvian market

    • ARC Group Acquisition I Corp Announces the Separate Trading of its Ordinary Shares, Warrants and Rights

    • Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems

    • ARC Group Acquisition I Corp Announces Closing of $120,750,000 Initial Public Offering

    • ARC Group Acquisition I Corp Announces Pricing of $105,000,000 Initial Public Offering

    • ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER